References:
1. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis.2018;18(11):1191-1210.
2. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749-1759.
3. Nguyen-Van-Tam JS, O’Leary M, Martin ET, et al. Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries. Eur Respir Rev. 2022;31(166).
4. Binns E, Tuckerman J, Licciardi PV, Wurzel D. Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions.J Paediatr Child Health. 2022;58(10):1741-1746.
5. Soto JA, Stephens LM, Waldstein KA, Canedo-Marroquin G, Varga SM, Kalergis AM. Current Insights in the Development of Efficacious Vaccines Against RSV. Front Immunol.2020;11:1507.
6. McFarlane AJ, McSorley HJ, Davidson DJ, et al. Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota. J Allergy Clin Immunol. 2017(140):1068-1078.
7. Maizels RM. Regulation of immunity and allergy by helminth parasites. Allergy. 2020;75(3):524-534.
8. Schoggins JW, Wilson SJ, Panis M, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472(7344):481-485.
9. Schoggins JW. Interferon-Stimulated Genes: What Do They All Do? Annu Rev Virol. 2019;6(1):567-584.
10. Sposito B, Broggi A, Pandolfi L, et al. The interferon landscape along the respiratory tract impacts the severity of COVID-19. Cell. 2021;184(19):4953-4968 e4916.
11. McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A. Type I interferons in infectious disease. Nat Rev Immunol. 2015;15(2):87-103.
12. Khaitov MR, Laza-Stanca V, Edwards MR, et al. Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy. 2009;64(3):375-386.
13. Goritzka M, Makris S, Kausar F, et al. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. J Exp Med. 2015;212(5):699-714.
14. Lee PY, Li Y, Kumagai Y, et al. Type I interferon modulates monocyte recruitment and maturation in chronic inflammation. Am J Pathol. 2009;175(5):2023-2033.
15. Krausgruber T, Blazek K, Smallie T, et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol. 2011;12(3):231-238.
16. Askenasy N. Interferon and tumor necrosis factor as humoral mechanisms coupling hematopoietic activity to inflammation and injury. Blood Rev. 2015;29(1):11-15.
17. Essers MA, Offner S, Blanco-Bose WE, et al. IFNalpha activates dormant haematopoietic stem cells in vivo.Nature. 2009;458(7240):904-908.
18. Dalmas E, Toubal A, Alzaid F, et al. Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity. Nat Med.2015;21(6):610-618.
19. Kim TH, Kim CW, Oh DS, Jung HE, Lee HK. Monocytes Contribute to IFN-beta Production via the MyD88-Dependent Pathway and Cytotoxic T-Cell Responses against Mucosal Respiratory Syncytial Virus Infection. Immune Netw.2021;21(4):e27.
20. Muller U, Steinhoff U, Reis LF, et al. Functional role of type I and type II interferons in antiviral defense. Science. 1994;264(5167):1918-1921.
21. Johnston CJ, Robertson E, Harcus Y, et al. Cultivation of Heligmosomoides polygyrus: an immunomodulatory nematode parasite and its secreted products. J Vis Exp.2015(98):e52412.
22. Currie SM, Findlay EG, McHugh BJ, et al. The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus. PLoS One. 2013;8(8):e73659.
23. Plantinga M, Guilliams M, Vanheerswynghels M, et al. Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity. 2013;38(2):322-335.
24. Hawley CA, Rojo R, Raper A, et al. Csf1r-mApple Transgene Expression and Ligand Binding In Vivo Reveal Dynamics of CSF1R Expression within the Mononuclear Phagocyte System.J Immunol. 2018;200(6):2209-2223.
25. Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets.Immunobiology. 2006;211(6-8):609-618.
26. Ingersoll MA, Spanbroek R, Lottaz C, et al. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood. 2010;115(3):e10-19.
27. Yona S, Kim KW, Wolf Y, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 2013;38(1):79-91.
28. Hettinger J, Richards DM, Hansson J, et al. Origin of monocytes and macrophages in a committed progenitor.Nat Immunol. 2013;14(8):821-830.
29. Ali NM, Behnke JM, Manger BR. The pattern of peripheral blood leucocyte changes in mice infected with Nematospiroides dubius. J Helminthol. 1985;59(1):83-93.
30. Baker NF. The nature and etiology of the leukocytic response of Webster mice infected with Nematospiroides dubius. J Parasitol. 1962;48:438-441.
31. Dick SA, Wong A, Hamidzada H, et al. Three tissue resident macrophage subsets coexist across organs with conserved origins and life cycles. Sci Immunol.2022;7(67):eabf7777.
32. Desai P, Diamond MS, Thackray LB. Helminth-virus interactions: determinants of coinfection outcomes.Gut Microbes. 2021;13(1):1961202.
33. Chowaniec W, Wescott RB, Congdon LL. Interaction of Nematospiroides dubius and influenza virus in mice.Exp Parasitol. 1972;32(1):33-44.
34. Furze RC, Hussell T, Selkirk ME. Amelioration of influenza-induced pathology in mice by coinfection with Trichinella spiralis. Infect Immun. 2006;74(3):1924-1932.
35. Scheer S, Krempl C, Kallfass C, et al. S. mansoni bolsters anti-viral immunity in the murine respiratory tract. PLoS One. 2014;9(11):e112469.
36. Santos MP, Goncalves-Santos E, Goncalves RV, et al. Doxycycline aggravates granulomatous inflammation and lung microstructural remodeling induced by Schistosoma mansoni infection. Int Immunopharmacol. 2021;94:107462.
37. Reese TA, Wakeman BS, Choi HS, et al. Helminth infection reactivates latent gamma-herpesvirus via cytokine competition at a viral promoter. Science. 2014;345(6196):573-577.
38. Mylonas KJ, Jenkins SJ, Castellan RF, et al. The adult murine heart has a sparse, phagocytically active macrophage population that expands through monocyte recruitment and adopts an ’M2’ phenotype in response to Th2 immunologic challenge.Immunobiology. 2015;220(7):924-933.
39. Ogger PP, Garcia Martin M, Michalaki C, et al. Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS-CoV-2 in mice.Eur J Immunol. 2022;52(11):1768-1775.
40. Channappanavar R, Fehr AR, Vijay R, et al. Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe. 2016;19(2):181-193.
41. Garcia-Sastre A, Durbin RK, Zheng H, et al. The role of interferon in influenza virus tissue tropism.J Virol. 1998;72(11):8550-8558.
42. Price GE, Gaszewska-Mastarlarz A, Moskophidis D. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice. J Virol.2000;74(9):3996-4003.
43. Lee AJ, Chen B, Chew MV, et al. Inflammatory monocytes require type I interferon receptor signaling to activate NK cells via IL-18 during a mucosal viral infection. J Exp Med. 2017;214(4):1153-1167.
44. D’Souza SS, Zhang Y, Bailey JT, et al. Type I Interferon signaling controls the accumulation and transcriptomes of monocytes in the aged lung. Aging Cell.2021;20(10):e13470.
45. Bosteels C, Neyt K, Vanheerswynghels M, et al. Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection. Immunity. 2020;52(6):1039-1056 e1039.
46. Aegerter H, Lambrecht BN, Jakubzick CV. Biology of lung macrophages in health and disease.Immunity. 2022;55(9):1564-1580.
47. T’Jonck W, Bain CC. The role of monocyte-derived macrophages in the lung: It’s all about context.Int J Biochem Cell Biol. 2023;159:106421.
48. Han S, Zhuang H, Lee PY, et al. Differential Responsiveness of Monocyte and Macrophage Subsets to Interferon. Arthritis Rheumatol. 2020;72(1):100-113.
49. Pogue SL, Preston BT, Stalder J, Bebbington CR, Cardarelli PM. The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells.J Interferon Cytokine Res. 2004;24(2):131-139.
50. Dickensheets HL, Donnelly RP. Inhibition of IL-4-inducible gene expression in human monocytes by type I and type II interferons. J Leukoc Biol. 1999;65(3):307-312.
51. Tong Y, Zhou L, Yang L, et al. Concomitant type I IFN and M-CSF signaling reprograms monocyte differentiation and drives pro-tumoral arginase production.EBioMedicine. 2019;39:132-144.
52. Fraser E, Denney L, Antanaviciute A, et al. Multi-Modal Characterization of Monocytes in Idiopathic Pulmonary Fibrosis Reveals a Primed Type I Interferon Immune Phenotype.Front Immunol. 2021;12:623430.
53. Simon HU, Seelbach H, Ehmann R, Schmitz M. Clinical and immunological effects of low-dose IFN-alpha treatment in patients with corticosteroid-resistant asthma.Allergy. 2003;58(12):1250-1255.
54. van Boxel-Dezaire AH, Rani MR, Stark GR. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity. 2006;25(3):361-372.
55. Winkler ES, Shrihari S, Hykes BL, Jr., et al. The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis.Cell. 2020;182(4):901-918 e918.
56. Erttmann SF, Swacha P, Aung KM, et al. The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis. Immunity. 2022;55(5):847-861 e810.
57. Kennedy MHE, Brosschot TP, Lawrence KM, et al. Small Intestinal Levels of the Branched Short-Chain Fatty Acid Isovalerate Are Elevated during Infection with Heligmosomoides polygyrus and Can Promote Helminth Fecundity.Infect Immun. 2021;89(12):e0022521.
58. Reynolds LA, Smith KA, Filbey KJ, et al. Commensal-pathogen interactions in the intestinal tract: lactobacilli promote infection with, and are promoted by, helminth parasites. Gut Microbes. 2014;5(4):522-532.
59. Di Scala M, Gil-Farina I, Vanrell L, et al. Chronic exposure to IFNalpha drives medullar lymphopoiesis towards T-cell differentiation in mice. Haematologica.2015;100(8):1014-1022.
60. Siakaeva E, Pylaeva E, Spyra I, et al. Neutrophil Maturation and Survival Is Controlled by IFN-Dependent Regulation of NAMPT Signaling. Int J Mol Sci. 2019;20(22).
61. Nguyen-Jackson H, Panopoulos AD, Zhang H, Li HS, Watowich SS. STAT3 controls the neutrophil migratory response to CXCR2 ligands by direct activation of G-CSF-induced CXCR2 expression and via modulation of CXCR2 signal transduction.Blood. 2010;115(16):3354-3363.
62. Grainger JR, Wohlfert EA, Fuss IJ, et al. Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection. Nat Med.2013;19(6):713-721.
63. Buechler MB, Akilesh HM, Hamerman JA. Cutting Edge: Direct Sensing of TLR7 Ligands and Type I IFN by the Common Myeloid Progenitor Promotes mTOR/PI3K-Dependent Emergency Myelopoiesis. J Immunol. 2016;197(7):2577-2582.
64. Chenery AL, Antignano F, Hughes MR, Burrows K, McNagny KM, Zaph C. Chronic Trichuris muris infection alters hematopoiesis and causes IFN-gamma-expressing T-cell accumulation in the mouse bone marrow. Eur J Immunol. 2016;46(11):2587-2596.
65. Askenase MH, Han SJ, Byrd AL, et al. Bone-Marrow-Resident NK Cells Prime Monocytes for Regulatory Function during Infection. Immunity. 2015;42(6):1130-1142.
66. Schoenemeyer A, Barnes BJ, Mancl ME, et al. The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J Biol Chem.2005;280(17):17005-17012.
67. Corbin AL, Gomez-Vazquez M, Berthold DL, et al. IRF5 guides monocytes toward an inflammatory CD11c(+) macrophage phenotype and promotes intestinal inflammation.Sci Immunol. 2020;5(47).
68. Progatzky F, Shapiro M, Chng SH, et al. Regulation of intestinal immunity and tissue repair by enteric glia. Nature. 2021;599(7883):125-130.
69. Michalska A, Blaszczyk K, Wesoly J, Bluyssen HAR. A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses. Front Immunol. 2018;9:1135.
70. Nasr N, Maddocks S, Turville SG, et al. HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. Blood. 2012;120(4):778-788.
71. Lee D, Le Pen J, Yatim A, et al. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children. Science.2023;379(6632):eabo3627.
72. Fagone P, Nunnari G, Lazzara F, et al. Induction of OAS gene family in HIV monocyte infected patients with high and low viral load. Antiviral Res. 2016;131:66-73.
73. Teng TS, Foo SS, Simamarta D, et al. Viperin restricts chikungunya virus replication and pathology.J Clin Invest. 2012;122(12):4447-4460.